Nature of Disclosure: Regulatory filing pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding allotment of equity shares to an ESOP Trust.
Key Event: The Administrative Committee of the Board of Directors, at its meeting held on 5th June 2026, allotted 21,00,000 equity shares of ₹10 each fully paid-up to the Piramal Pharma Limited Employees Welfare Trust under the Piramal Pharma Limited - Employee Stock Option and Incentive Plan – 2022.
Share Details:
- Face value: ₹10 per share
- Number of shares allotted: 21,00,000
- Distinctive numbers: From 2276497937 to 2278597936
- Exercise price per share: ₹10
- Premium per share: Not applicable
- Share certificate number: Not applicable
- Lock-in details: Not applicable
Capital Structure Impact:
- Pre-allotment paid-up share capital: ₹1,329,24,81,300 (132,92,48,130 equity shares)
- Post-allotment paid-up share capital: ₹1,331,34,81,300 (133,13,48,130 equity shares)
- Increase in share capital: ₹2,10,00,000
Regulatory Compliance:
- Disclosure made under Regulation 30 of SEBI Listing Regulations
- Requisite disclosure under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 enclosed as Annexure A
- Statement referred in regulation 10(b) was filed with BSE and NSE on 20th March, 2024 (BSE Filing No.: 198227, NSE Filing No.: 40737)
Listing Fees Paid:
- BSE Limited: ₹5,259.60 (inclusive of GST), UTR: AXISP00804603508, Date: 3rd June, 2026
- National Stock Exchange of India Limited: ₹5,534.50 (inclusive of GST), UTR: AXISP00804603509, Date: 3rd June, 2026
Purpose: The shares allotted to the ESOP Trust shall be transferred to or for the benefit of Eligible Employees upon exercise of their Options under the ESOP Scheme.
Company Information:
- Listed on: BSE Limited and National Stock Exchange of India Limited